Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia and UCSF Partnering to Deliver AI Apps to Improve Cancer Diagnosis

By Author Proscia | March 19, 2020

Proscia and the University of California San Francisco (UCSF) are partnering to use artificial intelligence (AI) to improve the accuracy and speed of cancer diagnoses, starting with prostate cancer. The collaboration will seek to validate the use of computational applications for pathology subspecialties such as prostate cancer, the second-leading cause of cancer deaths among U.S. males, with 191,930 new cases expected this year, according to the American Cancer Society.

Our website uses cookies. By using this site, you agree to its use of cookies.